SavedAdd your journal

Journals / Southern Clinics of Istanbul Eurasia / 2022 / Cilt: 33 - Sayı: 1

Hypercalcemia After Kidney Transplantation: A Single-Center Experienc

Murat GÜCÜN
Gülizar ŞAHİN MANGA
Pages
32–36
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

While there was no significant difference in alkaline phosphatase levels (ALP) (p=0.720) at the time of transplantation, a significant difference was found in ALP in the 12th-month measurements (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To examine the causes of hypercalcemia developing after kidney transplantation and investigate its effects on graft functions.
📊
Key Findings & Data:Methods: The results of 104 patients were explored retrospectively.
💡
Conclusion & Impact:While there was no significant difference in alkaline phosphatase levels (ALP) (p=0.720) at the time of transplantation, a significant difference was found in ALP in the 12th-month measurements (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To examine the causes of hypercalcemia developing after kidney transplantation and investigate its effects on graft functions. Methods: The results of 104 patients were explored retrospectively. Patients assigned according to calcium levels at 12th month after transplantation as hypercalcemia group (Ca2+ >10.2) and normocalcemia (Ca2+ ≤10.2) group. Glomerular filtration rates were calculated using the Chronic Kidney Disease Epidemiology Collaboration equation for each follow-up period. Results: A total of 104 patients, 30 (29%) females and 74 (71%) males, were included in our study. Patients were divided into two groups as hypercalcemic (Ca2+ >10.2) (n=30, 29%) and normocalcemic (Ca2+ ≤10.2) (n=74, 71%) according to their 12-month follow-up results. While there was no significant difference in alkaline phosphatase levels (ALP) (p=0.720) at the time of transplantation, a significant difference was found in ALP in the 12th-month measurements (p

🔖

Cite This Article

GÜCÜN, M., MANGA, G. Ş. (2022). Hypercalcemia After Kidney Transplantation: A Single-Center Experienc. Southern Clinics of Istanbul Eurasia, Cilt: 33 - Sayı: 1, 32–36. https://ajindex.com/articles/592714

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Amiri FS, Khatami MR. Fibroblast Growth Factor 23 in postrenal transplant: An often forgotten hormone. Exp Clin Transplant 2016;14:606–16
  2. Borchhardt K, Sulzbacher I, Benesch T, Fodinger M, SunderPlassmann G, Haas M. Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation. Am J Transplant 2007;7:2515–21
  3. Muirhead N, Zaltman JS, Gill JS, Churchill DN, Poulin-Costello M, Mann V, et al. Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice. Clin Transplant 2014;28:161–5
  4. Messa P, Cafforio C, Alfieri C. Clinical impact of hypercalcemia in kidney transplant. Int J Nephrol 2011;2011:906832
  5. Taweesedt PT, Disthabanchong S. Mineral and bone disorder after kidney transplantation. World J Transplant 2015;5:231–42
  6. Wolf M, Weir MR, Kopyt N, Mannon RB, Von Visger J, Deng H, et al. A prospective cohort study of mineral metabolism after kidney transplantation. Transplantation 2016;100:184–93
  7. Vangala C, Pan J, Cotton RT, Ramanathan V. Mineral and bone disorders after kidney transplantation. Front Med (Lausanne) 2018;5:211
  8. Evenepoel P, Van Den Bergh B, Naesens M, De Jonge H, Bammens B, Claes K, et al. Calcium metabolism in the early posttransplantation period. Clin J Am Soc Nephrol 2009;4:665–72
  9. Parmaksız E, Meşe M, Yalın SF, Haras AB, Akyüz O, Bahçebaşı ZB. Parathyroidectomy after kidney transplantation: a single-center experience. South Clin Ist Euras 2018;29:194–7
  10. Lambers TT, Bindels RJ, Hoenderop JG. Coordinated control of renal Ca2+ handling. Kidney Int 2006;69:650–4
  11. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005;289:F8–28
  12. Coburn JW, Koppel MH, Brickman AS, Massry SG. Study of intestinal absorption of calcium in patients with renal failure. Kidney Int 1973;3:264–72
  13. Heaf J, Tvedegaard E, Kanstrup IL, Fogh-Andersen N. Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant 2000;14:457–63
  14. Hiemstra TF, Brown AJ, Chaudhry AN, Walsh M. Association of calcium, phosphate and parathyroid hormone with renal allograft function: a retrospective cohort study. Am J Nephrol 2013;37:339– 45
  15. Ozdemir FN, Afsar B, Akgul A, Usluoğullari C, Akçay A, Haberal M. Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients. Transplant Proc 2006;38:480–2
  16. Habbig S, Beck BB, Feldkötter